Magnetar Financial’s AnaptysBio ANAB Stock Holding History

Magnetar Financial’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,383	Closed	-$201K	–	715
2017 Q2	$201K	Buy	+8,383	New	+$211K	﹤0.01%	694

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Magnetar Financial's ANAB Position: Q3 2017 in Review

Magnetar Financial sold out of AnaptysBio (ANAB) in Q3 2017, closing a stake of 8,383 shares — an estimated $201K sold.

Magnetar Financial first reported a position in ANAB in Q2 2017 and held it in 1 quarter. The position peaked at $201K in Q2 2017. 71 funds tracked by Wall St. Rank hold ANAB as of Q3 2017.

Magnetar Financial reported no remaining AnaptysBio position as of Q3 2017 after selling out during the quarter.
Magnetar Financial sold 8,383 AnaptysBio shares in Q3 2017, an estimated $201K.
Magnetar Financial first reported a position in AnaptysBio in Q2 2017 and held it in 1 quarter.
Magnetar Financial's AnaptysBio position peaked at $201K in Q2 2017.
71 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2017.

Based on Magnetar Financial's 13F filing for Q3 2017, filed 14 Nov 2017.